Katie Kane
- LATE-BREAKING ABSTRACT: A Phase 1b study of PUR0200, a novel tiotropium formulation, in COPD patientsBy David Hava, Katie Kane, Fred Reid, Arjun Ravi, Jo Collier, Tess Schmalbach and Dave SinghDavid Hava1Clinical Development, Pulmatrix Inc, Lexington, MA United StatesKatie Kane1Clinical Development, Pulmatrix Inc, Lexington, MA United StatesFred Reid2Medicines Evaluation Unit, Wythenshaw Hospital, Manchester, United KingdomArjun Ravi2Medicines Evaluation Unit, Wythenshaw Hospital, Manchester, United KingdomJo Collier3Clinical Research, Quotient Clinical, Nottingham, United KingdomTess Schmalbach1Clinical Development, Pulmatrix Inc, Lexington, MA United StatesDave Singh2Medicines Evaluation Unit, Wythenshaw Hospital, Manchester, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.